期刊文献+

前列腺癌内分泌治疗研究进展 被引量:1

原文传递
导出
摘要 前列腺癌的内分泌治疗已有 60多年的历史。目前抗雄治疗的手段多样 ,临床应用不断扩大 ,但是内分泌治疗的实际意义 (益处 ) ,在许多情况下尚未确定。本文从循证医学的角度 ,对前列腺癌内分泌治疗的有关问题作一综述。
出处 《国际泌尿系统杂志》 2004年第S1期34-37,共4页 International Journal of Urology and Nephrology
关键词 前列腺肿瘤
  • 引文网络
  • 相关文献

参考文献17

  • 1ByarDP,CorleDK.Hormonetherapyforprostatecancer:resultsoftheVeteransAdministrationCooperationUrologicalResearchGroupStudies. NCIMonogr . 1988
  • 2WirthM,TyrrellC,WallaceM ,etal.Bicalutamide(Casodex)150mgasimmediatetherapyinpatientswithlocalizedorlocallyadvancedprostatecancersignificantlyreducestheriskofdiseaseprogression. Urology . 2001
  • 3PoundCR,PartinAW,EisenbergerMA ,etal.Naturalhistoryofprogres sionafterPSAelevationfollowingradicalprostatectomy. The Journal of The American Medical Association . 1999
  • 4MilbankAJ,DreicerR,KleinEA.Hormonaltherapyforprostatecancer:primumnonnocere. Urology . 2002
  • 5ByarDP.ProceedingsoftheveteransAdministrationCooperativeUrologi calResearchGroup’’sstudiesofcanceroftheprostate. Cancer . 1973
  • 6BailarJC,ByarDP.Estrogentreatmentforcanceroftheprostate:earlyre sultswith3dosesofdiethylstilbestrolandplacebo. Cancer . 1970
  • 7KiekD.FortheMedicalResearchCouncilProstateCancerWorkingPartyInvestigatorsGroup:Immediateversusdeferredhormonetreatmentforprostatecancer:howsafeisandrogendeprivation?. BJUInt . 2000
  • 8EisenbergerMA,WalshPC.Earlyandrogendeprivationforprostatecan cer?. The New England Journal of Medicine . 1999
  • 9GranforsT,ModigH,DamberJE ,etal.Combinedorchiectomyandexter nalradiotherapyversusradiotherapyalonefornonmetastaticprostatecan cerwithorwithoutpelviclymphnodeinvolvement:aprospectiverandom izedstudy. The Journal of Urology . 1998
  • 10BollaM,GonzalezD,WardeP ,etal.Improvedsurvivalinpatientswithlocallyadvancedprostatecancertreatedwithradiotherapyandgoserelin. The New England Journal of Medicine . 1997

同被引文献18

  • 1鲍海咏.胃癌内分泌治疗研究进展[J].青海医药杂志,2007,37(12):69-72. 被引量:2
  • 2陈莉,姜军,杨新华,范林军,陈显春.乳腺癌端粒酶逆转录酶mRNA和BRCA1蛋白表达及其相互关系[J].中国普外基础与临床杂志,2006,13(4):434-436. 被引量:3
  • 3杨名添,连臻强.乳腺癌内分泌治疗的进展[J].癌症,2007,26(4):440-444. 被引量:13
  • 4Marc L,Guy L.The"portrait"of hereditary breat cancer[J].Breat Cancer Res and Trea,2005,(89):297-304.
  • 5Jones PA,Baylin S B.The fundamental role of ep igenetic events incancer[J].Nat Rev Genet,2002,(3):415-428.
  • 6Imogen L,Zs Ofia KJ,Elizabeth B,et al.Loss of heter ozygosity at the BRCA1 and BRCA2 loci deteced in ductal lavage fluid from BRCA gene mutati on carriers and contr ols[J].Cancer Epidemiol Biomarkers Prev,2006,7(15):1399-1402.
  • 7Trachtenberg J G M S C.A phase 3,multicenter,open label,randomized study of abarelix versus leuprolide pius daily antiandrogen in men with prostate cancer[J].J Urol,2002,(167):1670-1674.
  • 8Lonning PE.Clinico-pharmacilogical aspects of different horm one treatment[J].Eur J Cancer,2000,14(36):81-82.
  • 9Howe IIA,Cuzick J,B aum M,et al.Results of the ATAC(Arim idex,Tam ox ifen,Alone or and Comb ination)trialaftercom pletion of 5 years adjuvant treatment for breats cancer[J].Lancet,2005,(365):60-62.
  • 10Tokunage A,Nishi K,Matsukura N,et al.Estrogen and progesterone receptors in gastric cancer[J].Cancer,1986,57(7):1376-1379.

引证文献1

;
使用帮助 返回顶部